[S01-1]TBA
○Florent Ginhoux(Gustave Roussy, Grand Paris, France)
The 21st Awaji International Forum on Infection and Immunity
Sep 3 - Sep 6, 2023Karuizawa Prince Hotel West
You can search for presentations in this event.
SearchThe 21st Awaji International Forum on Infection and Immunity
Sep 3 - Sep 6, 2023Karuizawa Prince Hotel West
You can search for presentations in this event.
SearchSearch Results(149)
[S01-2]Virus variation, evolution and the quest for life-attenuated vaccines
○Raul Andino1, Yeh Ming Te2, MacAdam Andrew3(1.Microbiology and Immunology, UCSF and Osaka University, 2.Biken, Osaka University, 3.NIBSC United Kingdom)
[S02-1]Human immunity to infection and vaccination.
○Bali Pulendran(Stanford University, Institute for Immunity, Transplantation and Infection)
[S02-2]The enigmatic role of CD8 T cells in immunity to tuberculosis
○Samuel M Behar(University Massachusetts Chan Medical School)
[S02-3]Science and Design of Nucleic Acid-based Vaccine and Adjuvant
○Ken J. Ishii1,2,3(1.Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo (IMSUT), 2.International Vaccine Design Center (vDESC), IMSUT, 3.UTOPIA, U Tokyo)
[S02-4 (P-06)]The design of broadly protective B cell and T cell betacoronavirus vaccines using artificial intelligence
Brandon Malone1, Ioannis Vardaxis1, Boris Simovski1, Simen Tennoe1, Marius Gheorghe1, Agnieszka Gromadka1, Kousuke Onoue4, Yuki Tanaka4, Sebastian Kapell1, Pierre Machart3, Roman Volchenkov3, Onoguchi Kazuhide1, Richard Stratford4, ○Trevor Clancy1,2(1.NEC OncoImmunity, Norway, 2.Institute of Tropical Medicine, Nagasaki University, Japan, 3.NEC Research Laboratories Europe, Germany, 4.NEC Corporation, Japan)
[S03-1]Immune regulation via bacterial components and metabolites and its application to the development of vaccine adjuvant and immunotherapy
○Jun Kunisawa(Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition)
[S03-2]Deconvoluting Human Respiratory Mucosal Immune Responses
○James Di Santo(Innate Immunity Unit, Inserm U1223, Institut Pasteur, Paris, France)
[S03-3 (P-79)]Vaccine-inducing lung resident memory Th2 cells protect against lethal pulmonary cryptococcosis
○Keigo Ueno, Miyazaki Yoshitsugu(Department of Fungal Infection, National Institute of Infectious Diseases)
[S03-4 (P-83)]Insight into neutrophil phenotypic alterations in relation to the severity of pneumococcal infection with age
○Masaya Yamaguchi1,2, Momoko Kobayashi3, Kunio Kawanishi4, Masayuki Ono3, Daisuke Motooka5, Daisuke Okuzaki2,5,6, Shigetada Kawabata2,3(1.Bioinformatics Research Unit, Osaka University, Graduate School of Dentistry, Japan, 2.Osaka University, Center for Infectious Disease Education and Research, Japan, 3.Department of microbiology, Osaka University, Graduate School of Dentistry, Japan, 4.Faculty of Medicine, University of Tsukuba, Japan, 5.Research Institute for Microbial Diseases, Osaka University, Japan, 6.WPI Immunology Frontier Research Center, Osaka University, Japan)
[S04-1]Toward development of defined microbial therapeutics
○Kenya Honda1,2(1.Keio University School of Medicine, 2.RIKEN Center for Integrative Medical Sciences)
[S04-2]The intersection of adaptive and innate immunity in the lung: implications for chronic pulmonary insufficiency
Satomi Ito1, Baihao Zhang1, Seiko Narushima1, Yuki Sugiura2, ○Sidonia Fagarasan1,3(1.Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan, 2.Multiomics Platform, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3.Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan)
[S04-3]Evolution of the human gut microbiota
○Taichi Suzuki(Biodesign Center for Health Through Microbiomes and College of Health Solutions, Arizona State University, USA)
[S04-4 (P-13)]Dual Impacts of a Glycan Shield on the Envelope Glycoprotein B of HSV-1:Evasion from Human Antibodies In Vivo and Neurovirulence
○Ayano Fukui, Maruzuru Yuhei, Nobe Moeka, Iwata Shuji, Takeshima Kosuke, Koyanagi Naoto, Kato Akihisa, Kawaguchi Yasushi(Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
[S05-1]Heterogeneity in Antimicrobial Resistance
○Yukihiro Akeda1,2(1.Department of Bacteriology I, National Institute of Infectious Diseases, Japan, 2.Research Institute for Microbial Diseases, Osaka University)
[S05-2]Therapeutic application of angiotensin converting enzyme 2 (ACE2) enzyme activity on severe acute lung injury in COVID-19
○Keiji Kuba(Kyushu University Graduate School of Medical Sciences)
[S05-3 (P-48)]Insights into innate immunity against SARS-CoV-2
○Rayhane Nchioua1, Caterina Prelli-Bozzo1, Dorota Kmiec1, Fabian Zech1, Sabrina Noettger1, Annika Schundner2, Manfred Frick2, Steffen Just3, Konstantin M. J. Sparrer1, Frank Kirchhoff1(1.Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany, 2.Institute of General Physiology, Ulm University, 3.Molecular Cardiology, Department of Internal Medicine II, Ulm University, Ulm, Germany)
[S05-4 (P-92)]Bidirectional interactions between gut microbes and the host under artificial hibernation
○Reina Miyajima1, Takahiro Yamada1,2, Genshiro Sunagawa3, Takeshi Sakurai4, Koji Hase1(1.Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, 2.Department of Immunobiology, Yale School of Medicine, 3.Laboratory for Hibernation Biology, RIKEN Center for Biosystems Dynamics Research, 4.Faculty of Medicine, University of Tsukuba)
[S06-1]Host-Plasmodium interaction: a tale of symbiosis and pathogenesis.
○Maria Mota(Instituto de Medicina Molecular Joao Lobo Antunes, Portugal)
[S06-2]Towards malaria eradication, what have we learned from our own immune system: vaccines or drugs?
○Cevayir Coban(Institute of Medical Science (IMSUT), the University of Tokyo Division of Malaria Immunology)
[S06-3 (P-05)]Development of a system to evaluate the expression of exogenously introduced molecules on the surface of infected red blood cells by Plasmodium knowlesi
Yuka Appelboom1,2,3, ○Huai Chuang2,3, Yuko Katakai4, Satoru Kawai5, Miako Sakaguchi6, Osamu Kaneko2,3(1.Master's program of Biomedical Sciences, Leiden University Medical Center, Leiden University, Netherland, 2.Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Japan, 3.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 4.The Corporation for Production and Research of Laboratory Primates, Japan, 5.Department of Tropical Medicine and Parasitology, Dokkyo Medical University, Japan, 6.Central Laboratory, Institute of Tropical Medicine, Nagasaki University, Japan)
[S06-4 (P-03)]A centringene-deleted Leishmaniavaccine candidate: early and late surrogate markers of immunogenicity
○Jalal Alshaweesh1, Ranadhir Dey2, Telly Sepahpour2, Kamaleshwar Singh3, Patrick Lypaczewski4, Subir Karmakar3, Swarnendu Kaviraj3, Sanjay Singh3, Nazli Azodi2, Sreenivas Gannavaram2, Abhay Satoskar5, Greg Matlashewski4, Hira Nakhasi2, Shinjiro Hamano1(1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, USA, 3.Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra, India, 4.Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada, 5.Department of Pathology and Microbiology, Ohio State University, Columbus, OH, USA)
[S07-1]Crimean-Congo Hemorrhagic Fever
○Önder Ergönül(Koc University School of Medicine)
[S07-2]Inter-regional study of transmission, adaptation, and pathogenesis of viruses with pandemic potential
○Anavaj Sakuntabhai1,2,3(1.Pasteur International Research Center for Emerging Infectious Diseases (PICREID), 2.Ecology and Emergence of Arthropod-borne Pathogens unit, Department of Global Health, Institut Pasteur, Paris, France, 3.International Vaccine Design Center (vDesC), The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan)
[S07-3]Pathogenesis of acute and chronic COVID-19
○Yumiko Imai(Project Leader of the Infection Medical Information Laboratory, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN))
[S07-4]SARS-CoV-2 Variants
○Ravindra Kumar Gupta(University of Cambridge)
[S08-1]SARS-CoV-2's origin and subsequent molecular evolution in humans
○David L Robertson(MRC-University of Glasgow Centre for Virus Research, Scotland)
[S08-2]Evolution of SARS-CoV-2 and beyond
○Kei Sato(The Institute of Medical Science, The University of Tokyo, Japan)
[S08-3 (P-78)]Identification of a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses
○Kentaro Uemura1,2,3,4,5, Haruaki Nobori2, Akihiko Sato2,3,6, Shinsuke Toba2,3, Shinji Kusakabe2,3, Michihito Sasaki3, Yasuko Orba3, Yoshiharu Matsuura4,5, Hirofumi Sawa3,6, Akira Matsuda7, Katsumi Maenaka1,6,7,8(1.Faculty of Pharmaceutical Sciences, Hokkaido University, Japan, 2.Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Japan, 3.International Institute for Zoonosis Control, Hokkaido University, Japan, 4.Center for Infectious Disease Education and Research, Osaka University, Japan, 5.Research Institute for Microbial Diseases, Osaka University, Japan, 6.Institute for Vaccine Research and Development, Hokkaido University, Japan, 7.Center for Research and Education on Drug Discovery, Hokkaido University, Japan, 8.Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Japan)
[S08-4 (P-53)]Suppression of SARS-CoV-2 propagation by siRNA targeting the stem-loop structures in the 5'UTR
○Chikako Ono1,2, Masanao Sato3, Kentaro Uemura1,2, Junki Hirano1,2, Shuhei Taguwa1,2, Yoshiharu Matsuura1,2(1.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan., 2.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan., 3.Laboratory of Applied Molecular Entomology, Research Faculty of Agriculture, Hokkaido University, Sapporo, Japan)
[S09-1]Understanding SARS-CoV-2 Variants through Reverse Genetics
○Melanie Ott1,2, Taha Taha1, Syed Abdullah1, Chen Irene1, Hayashi Jennifer1, Doudna Jennifer1(1.Gladstone Institute of Virology, 2.University of California San Francisco)
[S09-2]Newly identification of a CXCR6+ pathogenic skin-resident CD4+ T cell subset in a mouse model of allergic dermatitis that requires CXCL16 for its maintenance
○Kenji Kabashima(Kyoto University Graduate School of Medicine)
[S09-3 (P-42)]Lethal Cytokine Storm and Microthrombosis After mRNA Booster Vaccination
○Yuki Masuo1,2, Hiroyuki Yoshitomi1, Yoshitaka Honda1,3, Hajime Morita1, Shuhe Ma1,3, Takao Hashiguchi2,4, Akihiko Sugimoto5, Sachiko Minamiguchi5, Hironori Haga5, Tatsuya Kamitori6, Hideki Yokoi7, Takamoto Hirota8, Kinta Hatakeyama9, Yoshihiko Ikeda9, Keiko Ohta-Ogo9, Masanori Matsumoto10, Tomoya Hayashi11, Ken J. Ishii11, Fumihiro Fujiki12, Tadaki Suzuki13, Shun Iida13, Harutaka Katano13, Hideki Ueno1,2,3(1.Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2.Kyoto University Immunomonitoring Center, Kyoto University, Kyoto, Japan, 3.ASHBi Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan, 4.Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan, 5.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 6.Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan, 7.Department of Nephrology, Kyoto University Hospital, Kyoto, Japan, 8.Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan, 9.Department of Pathology, National Cerebral and Cardiovascular Center Hospital, Suita, Japan, 10.Department of Hematology, Nara Medical University, Kashihara, Japan, 11.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 12.Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan, 13.Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan)
[S09-4 (P-58)]Multimodal analysis of COVID-19, Bacterial Sepsis and mRNA vaccination cohorts reveals SARS-CoV2 specific subpopulations of activated memory B-cells
○David G Priest1, Janyerkye Tulyeu1,2, Jonas N Sondergaard1,2, Yuki Togami3, Yumi Mitsuyama4, Shuhei Sakakibara5, Takeshi Ebihara3, Hisatake Matsumoto3, Hiroshi Ogura3, James B Wing1,2(1.Laboratory of Human Single Cell Immunology, iFReC, Osaka University, 2.Human Single Cell Immunology Team, CiDER, Osaka University, 3.Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 4.Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 5.Laboratory of Immune Regulation, iFReC, Osaka University)
[S10-1]Structural Biological Studies towards Prevention and Therapy against Infectious and Adult Diseases
Kazuhiro Sawada, Hiroaki Akasaka, Ryosuke Zaitsu, Ikko Nureki, Satoshi N. Omura, Ryoya Nakagawa, Wata Shihoya, ○Osamu Nureki(Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan)
[S10-2]Adaptive immune receptor repertoires as biomarkers for infection and disease
○Daron M Standley1,2, Zichang Xu1,2, Dianita Saputri1(1.Research Institute for Microbial Diseases, Osaka University, Japan, 2.Immunology Frontier Research Center, Osaka University, Japan)
[S10-3 (P-47)]Influenza A virus circumvents the innate immune response through the concealment of double-stranded RNA
○Masahiro Nakano1,2,3, Ohnishi Chiho1, Muramoto Yukiko1,2,3, Noda Takeshi1,2,3(1.Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Japan, 2.Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, Japan, 3.CREST, Japan Science and Technology Agency, Japan)
[S10-4 (P-51)]Archaeal glycerolipids are recognized by C-type lectin receptor Mincle
○Shiori Oka1, Miyuki Watanabe2,3, Emi Ito2,3, Ami Takeyama2,3, Takuro Matsuoka1, Norihito Arichi1, Hiroaki Ohno1, Sho Yamasaki2,3, Shinsuke Inuki1(1.Graduate School of Pharmaceutical Sciences, Kyoto University, Japan, 2.Research Institute for Microbial Diseases, Osaka University, Japan, 3.Immunology Frontier Research Center (IFReC), Osaka University, Japan)
[S11-1]Controlling pulmonary fibrosis - New therapeutic strategies approaching from the regulation of amino acid metabolism
○Noriko Toyama-Sorimachi(The Institute of Medical Science, The University of Tokyo (IMSUT))
[S11-2]Establishment of oral tolerance requires nutritional signals
○Koji Hase1,2, Nagai Motoyoshi3, Okawa Takuma1,4, Kawamura Yuki I.4, Dohi Takeko1,4(1.Faculty of Pharmacy, Keio University, 2.International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, the University of Tokyo (IMSUT), 3.National Institute of Allergy and Infectious Diseases, National Institutes of Health, 4.Research Institute, National Center for Global Health and Medicine)
[S11-3]Amino Acid Metabolism Controls the B-cell Epstein-Barr Virus Epigenome, Viral Gene Expression and Tumor Biology
Rui Guo, Shaowen White, Jin-Hua Liang, Yuchen Zhang, Michael Lutchenkov, Zhixuan Li, Yin Wang, ○Benjamin E. Gewurz(Division of Infectious Diseases, Brigham & Women's Hospital / Department of Microbiology, Harvard Medical School / Harvard Program in Virology / Center for Integrated Solutions to Infectious Diseases, Broad Institute of Harvard and MIT)
[S11-4 (P-54)]Pathogenic leptospires induce lipolysis in host adipocytes via adrenergic receptors to obtain their carbon sources.
○Ryo Ozuru, Ishii Kazunari, Fujiki Shotaro, Hiromatsu Kenji(Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University)
[S11-5 (P-19)]DAT, deacylating autotransporter toxin, from Bordetella parapertussis demyristoylates Gαi GTPases and contributes to cough
○Yukihiro Hiramatsu1, Nishida Takashi1, Horiguchi Yasuhiko1,2(1.Department of Molecular Bacteriology, RIMD, Osaka University, Japan, 2.CiDER, Osaka University)
[S12-1]Addressing the threat of emerging viral infections
○Yoshihiro Kawaoka1,2,3(1.University of Tokyo, 2.National Center for Global Health and Medicine, 3.University of Wisconsin-Madison)
[S12-2]cSIMVa: Developing pain-free and worry-free mucosal vaccines preventing pathogen invasion with society fostering vaccine trust.
○Hiroshi Kiyono(Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba)
[S12-3]Mission of the Center for Advanced Modality and DDS (CAMaD) at the Osaka University Synergy Center
○TOKIKO WATANABE1(1.Research Institute for Microbial Diseases, Osaka University, 2.The Center for Advanced Modality and DDS (CAMaD), Osaka University)
[S12-4]Research and Development of Vaccines at Nagasaki University in the SCARDA project
○Kouichi Morita(Institute of Tropical Medicine, Nagasaki University)
[S12-5]Activities of the Hokkaido University Institute for Vaccine Research and Development: HU-IVReD
○Hirofumi Sawa(Hokkaido University, Institute for Vaccine Research and Development : HU-IVReD)
[S12-6]-
Jerome Kim (IVI), Adam Hacker (CEPI), Osamu Kunii (GHIT Fund)
[P-01]Full Genome Characterization of Human G3P[6] Rotavirus Strain SO1199 Detected from a Diarrheic Child in Japan: Evidence for Porcine to Human Interspecies Transmission
○Yuki Akari1, Riona Hatazawa1, Manami Negoro2, Takaaki Tanaka3, Kazutoyo Asada4, Haruna Miwa4, Katsumi Sugiura4,5, Masakazu Umemoto6, Haruo Kuroki7, Hiroaki Ito8, Shigeki Tanaka9, Mitsue Ito10, Saori Fukuda1, Takayuki Murata1, Kiyosu Taniguchi4, Shigeru Suga4, Hajime Kamiya11, Takashi Nakano4, Koki Taniguchi1, Satoshi Komoto1,12(1.Department of Virology, Fujita Health University School of Medicine, Aichi, Japan, 2.Institute for Clinical Research, National Mie Hospital, Mie, Japan, 3.Department of Pediatrics, Kawasaki Medical School, Okayama, Japan, 4.Department of Pediatrics, National Mie Hospital, Mie, Japan, 5.Department of Pediatrics, Matsusaka Chuo General Hospital, Mie, Japan, 6.Umemoto Children's Clinic, Mie, Japan, 7.Child and Adult Clinic, Tokyo, Japan, 8.Department of Pediatrics, Kameda Medical Center, Chiba, Japan, 9.Department of Pediatrics, Mie Chuo Medical Center, Mie Japan, 10.Department of Pediatrics, Japanese Red Cross Ise Hospital, Mie, Japan, 11.Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan, 12.Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Oita, Japan)
149 results ( 1 - 50 )
- 1